HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas W Geisbert Selected Research

Ebola virus nucleoprotein VP35

7/2013Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas W Geisbert Research Topics

Disease

69Infections
01/2022 - 02/2002
42Vesicular Stomatitis
01/2022 - 06/2005
21Ebola Hemorrhagic Fever
01/2022 - 03/2002
17Fever (Fevers)
01/2021 - 12/2003
12COVID-19
03/2022 - 01/2020
9Virus Diseases (Viral Diseases)
01/2022 - 05/2010
9Marburg Virus Disease
01/2022 - 02/2007
8Lassa Fever (Fever, Lassa)
01/2020 - 06/2005
7Henipavirus Infections
11/2020 - 10/2010
5Filoviridae Infections
01/2014 - 11/2010
3Disease Progression
01/2021 - 03/2007
3Viremia
01/2020 - 05/2010
3Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
01/2019 - 06/2006
3Human Influenza (Influenza)
01/2017 - 10/2015
3Disseminated Intravascular Coagulation
10/2015 - 08/2005
2Crimean Hemorrhagic Fever
01/2021 - 01/2019
2American Hemorrhagic Fever (Bolivian Hemorrhagic Fever)
01/2021 - 04/2016
2Convalescence
08/2020 - 01/2020
2Interstitial Lung Diseases (Interstitial Lung Disease)
08/2020 - 01/2020
2Inflammation (Inflammations)
01/2020 - 08/2005
2Smallpox (Variola)
10/2004 - 01/2004
1Arthralgia (Joint Pain)
01/2022
1Vascular Skin Diseases
01/2022
1Arthritis (Polyarthritis)
01/2022
1Dermatitis
01/2022
1Cytokine Release Syndrome
01/2020
1Dengue (Dengue Fever)
01/2017
1Gaucher Disease (Gaucher's Disease)
01/2017
1Lymphopenia (Lymphocytopenia)
01/2017
1Paramyxoviridae Infections (Parainfluenza)
08/2015
1Venezuelan Equine Encephalomyelitis
08/2015
1Epidemic Louse-Borne Typhus (Typhus)
02/2015
1Leukemia
01/2014
1Neoplasms (Cancer)
01/2014
1Nervous System Diseases (Neurological Disorders)
12/2013

Drug/Important Bio-Agent (IBA)

56VaccinesIBA
01/2022 - 05/2002
44Glycoproteins (Glycoprotein)IBA
01/2022 - 06/2005
19Monoclonal AntibodiesIBA
03/2022 - 01/2007
11Antiviral Agents (Antivirals)IBA
01/2021 - 06/2006
9AntibodiesIBA
01/2022 - 11/2007
8AntigensIBA
12/2021 - 10/2010
8Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2003
6CytokinesIBA
01/2020 - 03/2002
5Neutralizing AntibodiesIBA
12/2021 - 01/2007
5Ebola VaccinesIBA
02/2015 - 01/2007
4Protein CIBA
11/2020 - 12/2003
4Small Interfering RNA (siRNA)IBA
12/2017 - 02/2014
4EnzymesIBA
10/2015 - 06/2005
4FibrinIBA
10/2015 - 11/2007
4Thromboplastin (Tissue Factor)IBA
11/2007 - 12/2003
3EpitopesIBA
03/2022 - 11/2007
3remdesivirIBA
01/2022 - 01/2021
3Combined VaccinesIBA
01/2021 - 01/2018
3Subunit VaccinesIBA
01/2021 - 08/2012
3AerosolsIBA
11/2020 - 12/2008
3ChemokinesIBA
01/2017 - 03/2002
3DNA (Deoxyribonucleic Acid)IBA
11/2016 - 01/2004
3LipidsIBA
01/2016 - 02/2014
3Ribavirin (Virazole)FDA LinkGeneric
10/2015 - 10/2010
2bamlanivimabIBA
12/2021 - 10/2020
2CollagenIBA
08/2020 - 01/2020
2Immunoglobulin M (IgM)IBA
01/2020 - 02/2015
2Immunoglobulin G (IgG)IBA
01/2020 - 02/2015
2InterferonsIBA
01/2017 - 07/2013
2GTP-Binding Proteins (G-Protein)IBA
10/2015 - 12/2013
2AnticoagulantsIBA
01/2014 - 11/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2010 - 10/2004
2Factor VIIa (Activated Factor VII)IBA
11/2007 - 12/2003
2RNA (Ribonucleic Acid)IBA
06/2006 - 12/2003
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021
1SolutionsIBA
01/2021
1Plasminogen Activator Inhibitor 1IBA
01/2021
1Recombinant ProteinsIBA
01/2020
1NucleoproteinsIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1HLA-DR Antigens (HLA-DR)IBA
01/2020
1Hormones (Hormone)IBA
01/2020
1ZincIBA
01/2020
1nitazoxanide (NTZ)FDA Link
09/2019
1Indicators and Reagents (Reagents)IBA
11/2018
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2018
1Polysaccharides (Glycans)IBA
11/2018
1miglustat (Zavesca)FDA Link
01/2017
1umifenovirIBA
01/2016
1Viral ProteinsIBA
01/2016
1Pharmaceutical PreparationsIBA
12/2015
1Pathogen-Associated Molecular Pattern MoleculesIBA
12/2015
1favipiravirIBA
10/2015
1Antifibrinolytic Agents (Antifibrinolytics)IBA
10/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2015
1salicylhydroxamic acid (SHAM)IBA
10/2015
1Fibrinogen (Factor I)FDA Link
10/2015
1ImmunosorbentsIBA
02/2015
1Lipid NanoparticlesIBA
02/2014
1myocardinIBA
01/2014
1CCAAT-Enhancer-Binding Protein-alphaIBA
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1attachment protein GIBA
12/2013

Therapy/Procedure

23Therapeutics
01/2022 - 03/2002
1Enteral Nutrition (Feeding, Tube)
01/2017